Cibus (CBUS) vs Tonix Pharmaceuticals (TNXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cibus (CBUS) has outperformed Tonix Pharmaceuticals (TNXP) over the past year, gaining 13.3% versus a loss of 67.2%. Over five years, CBUS leads with a -98.9% price change compared with -100.0% for TNXP. Tonix Pharmaceuticals is the larger company by market cap ($124.9 million vs $121.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBUS | TNXP |
|---|---|---|
| Share price | $1.59 | $7.28 |
| Market cap | $121.52M | $124.86M |
| 1-day change | -1.85% | -3.58% |
| YTD return | -6.90% | -51.66% |
| 1-year return | +13.29% | -67.17% |
| 5-year return | -98.90% | -100.00% |
| EPS (TTM) | $-1.62 | $-13.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $23.06 |
| 52-week low | $1.09 | $7.16 |
| Distance from 52-week high | -62.06% | -68.43% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +801.26% | +511.26% |
| Average volume | 206.34K | 537.49K |
| Shares outstanding | 76.43M | 17.15M |
| Employees | 118 | 142 |
| Sector | Industrials | Health Care |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBUS has outperformed TNXP by 80.5 percentage points over the past year.
- The two companies sit in different sectors: Cibus in Industrials and Tonix Pharmaceuticals in Health Care.
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Industrials · Agricultural Chemicals · 118 employees
About Tonix Pharmaceuticals
TNXP stock →Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia.
Health Care · Biotechnology: Pharmaceutical Preparations · 142 employees
CBUS vs TNXP FAQ
Which is bigger, Cibus or Tonix Pharmaceuticals?
Tonix Pharmaceuticals (TNXP) is larger, with a market capitalization of $124.86M compared with $121.52M for Cibus (CBUS).
Which stock has performed better over the past year, CBUS or TNXP?
CBUS returned +13.29% over the past 12 months, compared with -67.17% for TNXP (price return, excluding dividends). Past performance does not predict future results.
Are Cibus and Tonix Pharmaceuticals in the same industry?
No. Cibus is in the Industrials sector, while Tonix Pharmaceuticals is in Health Care.